⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

December 10, 2021Human Vaccines & ImmunotherapeuticsOpen Access

A rapid increase in the COVID-19 vaccination rate during the Olympic and Paralympic Games 2021 in Japan

Hirotake Mori Toshio Naito

View Full Paper

Ask AI

Bookmark

Share

Abstract

Increasing the vaccination rate is essential for controlling COVID-19. In April 2021, Japan’s vaccination rate was 4% before the Olympics and Paralympics.1 Nevertheless, the Japanese government pro...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Mori et al. (2021) studied this question.

synapsesocial.com/papers/6aa79f419bc59e3c3b96e6e2 https://doi.org/10.1080/21645515.2021.2010440

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling studyRetrospective Study · 2020 · 1,138 citations
2A qualitative evaluation of a STEAM (Science, technology, engineering, arts, and mathematics) peer education intervention on teenagers’ knowledge, confidence, and advocacy for HPV vaccine communicationHuman Vaccines & Immunotherapeutics · 2026
3From metastatic disease to no evidence of disease after conversion liver surgery in advanced gastric cancer with liver metastases: A case reportHuman Vaccines & Immunotherapeutics · 2026
4GMMA as adjuvant and carrier for mucosal delivery of group A streptococcus glycoconjugate vaccineHuman Vaccines & Immunotherapeutics · 2026
5HPV vaccination coverage and barriers for people with disability: A scoping reviewHuman Vaccines & Immunotherapeutics · 2026

Safety signals of tocilizumab in pediatric patients: A real-world pharmacovigilance analysis based on the FAERS database with network pharmacology insightsHuman Vaccines & Immunotherapeutics · 2026
Safety and immunogenicity of a first-generation modified vaccinia virus Ankara-vectored SARS-CoV-2 vaccine candidate with mRNA-based booster vaccination: A phase 1 trialHuman Vaccines & Immunotherapeutics · 2026
RSV vaccine uptake among Medicare Advantage enrollees: August 2023 to December 2024Human Vaccines & Immunotherapeutics · 2026
Development of mRNA vaccines against herpes zosterHuman Vaccines & Immunotherapeutics · 2026
Safety of nirsevimab in children aged 0–24 months: Analysis based on EudraVigilance data (2023–2025)Human Vaccines & Immunotherapeutics · 2026

More from Human Vaccines & Immunotherapeutics

More from Juntendo University